1
|
Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.
|
J Clin Oncol
|
2004
|
1.95
|
2
|
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
|
J Pain Symptom Manage
|
2005
|
0.96
|
3
|
Opioids and renal function.
|
J Pain
|
2004
|
0.93
|
4
|
Hyperalgesia: an emerging iatrogenic syndrome.
|
J Pain Symptom Manage
|
2003
|
0.91
|
5
|
Long-term central venous catheterization via persistent left superior vena cava: a case report.
|
Support Care Cancer
|
2003
|
0.88
|
6
|
Hyperalgesia and opioid switching.
|
Am J Hosp Palliat Care
|
2005
|
0.85
|
7
|
Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life.
|
J Pain Symptom Manage
|
2003
|
0.84
|
8
|
Pharmacological management of cancer pain in the elderly.
|
Drugs Aging
|
2007
|
0.84
|
9
|
Low morphine doses in opioid-naive cancer patients with pain.
|
J Pain Symptom Manage
|
2006
|
0.82
|
10
|
Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain.
|
Support Care Cancer
|
2005
|
0.81
|
11
|
Pain syndromes in haematological malignancies: an overview.
|
Hematol J
|
2004
|
0.80
|
12
|
Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management.
|
Anesth Analg
|
2005
|
0.80
|
13
|
When the progression of disease lowers opioid requirement in cancer patients.
|
Clin J Pain
|
2010
|
0.79
|
14
|
Opioids in pain management of blood-related malignancies.
|
Ann Hematol
|
2006
|
0.79
|
15
|
The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.
|
Support Care Cancer
|
2010
|
0.78
|
16
|
Pain in malignant hematology.
|
Expert Rev Hematol
|
2011
|
0.77
|
17
|
Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.
|
Tumori
|
2002
|
0.77
|
18
|
Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases.
|
Clin J Pain
|
2009
|
0.76
|
19
|
Beginning again from the end.
|
Palliat Med
|
2008
|
0.75
|
20
|
Sympathetic blocks and disease progression modifying pain mechanisms.
|
Reg Anesth Pain Med
|
2003
|
0.75
|
21
|
Prolonged uncontrolled pain, psychological distress, and opioid escalation.
|
J Pain Symptom Manage
|
2004
|
0.75
|
22
|
Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid responsiveness.
|
J Pain Symptom Manage
|
2002
|
0.75
|